• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含阿托伐他汀的自微乳化药物递送系统(SMEDDS)的制备与评价

Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.

作者信息

Shen HaiRong, Zhong MingKang

机构信息

Department of Pharmacy, Huashan Hospital, Fudan University, 12 Wulumuqi M. Road, Shanghai, 200040, China.

出版信息

J Pharm Pharmacol. 2006 Sep;58(9):1183-91. doi: 10.1211/jpp.58.9.0004.

DOI:10.1211/jpp.58.9.0004
PMID:16945176
Abstract

Atorvastatin is insoluble in aqueous solution and the bioavailability after oral administration is low. Self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin have been successfully prepared to improve its bioavailability. SMEDDS is a mixture of lipid, surfactant, and cosurfactant, which are emulsified in aqueous medium under gentle digestive motility in the gastrointestinal tract. Pseudo-ternary phase diagrams composed of various excipients were plotted. Droplet size, zeta-potential and long-term physical stability of the formulations were investigated. The release of atorvastatin from SMEDDS capsules was studied using the dialysis bag method in 0.1 M HCl and phosphate buffer (pH 7.4), compared with the release of atorvastatin from a conventional tablet. A pharmacokinetic study was performed in 6 beagle dogs after oral administration of 6 mg kg-1 atorvastatin. The bioavailability of atorvastatin SMEDDS capsules was significantly increased compared with that of the conventional tablet. SMEDDS capsules consisting of Labrafil, propylene glycol and Cremophor RH40 provided the greatest bioavailability. Our studies indicate that the use of SMEDDS for the delivery of atorvastatin can improve its bioavailability.

摘要

阿托伐他汀在水溶液中不溶,口服后的生物利用度较低。已成功制备了含阿托伐他汀的自微乳化药物递送系统(SMEDDS)以提高其生物利用度。SMEDDS是脂质、表面活性剂和助表面活性剂的混合物,在胃肠道温和的消化蠕动下于水性介质中乳化。绘制了由各种辅料组成的伪三元相图。研究了制剂的粒径、ζ电位和长期物理稳定性。使用透析袋法在0.1 M盐酸和磷酸盐缓冲液(pH 7.4)中研究了阿托伐他汀从SMEDDS胶囊中的释放情况,并与阿托伐他汀从常规片剂中的释放情况进行了比较。在6只比格犬口服6 mg kg-1阿托伐他汀后进行了药代动力学研究。与常规片剂相比,阿托伐他汀SMEDDS胶囊的生物利用度显著提高。由Labrafil、丙二醇和聚氧乙烯蓖麻油RH40组成的SMEDDS胶囊具有最高的生物利用度。我们的研究表明,使用SMEDDS递送阿托伐他汀可提高其生物利用度。

相似文献

1
Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.含阿托伐他汀的自微乳化药物递送系统(SMEDDS)的制备与评价
J Pharm Pharmacol. 2006 Sep;58(9):1183-91. doi: 10.1211/jpp.58.9.0004.
2
[Preparation and evaluation of self-microemulsifying drug delivery systems containing atorvastatin].[含阿托伐他汀的自微乳化药物递送系统的制备与评价]
Yao Xue Xue Bao. 2005 Nov;40(11):982-7.
3
Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS).自乳化药物传递系统(SEDDS)增强阿托伐他汀钙的口服生物利用度。
Pharm Dev Technol. 2011 Feb;16(1):65-74. doi: 10.3109/10837450903499333. Epub 2010 Jan 20.
4
Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.司骨化醇II的生物利用度:含中链和长链甘油三酯的口服自微乳化药物递送系统(SMEDDS)的开发与特性研究
Eur J Pharm Sci. 2006 Jun;28(3):233-42. doi: 10.1016/j.ejps.2006.02.005. Epub 2006 May 2.
5
Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs.用于提高辛伐他汀在比格犬体内口服生物利用度的自微乳化药物递送系统(SMEDDS)的研发。
Int J Pharm. 2004 Apr 15;274(1-2):65-73. doi: 10.1016/j.ijpharm.2003.12.028.
6
HPLC assay and pharmacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system.阿托伐他汀自微乳化药物递送系统口服给药后在比格犬体内的高效液相色谱测定及药代动力学研究
Pharmazie. 2006 Jan;61(1):18-20.
7
Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.含有长春西汀的自微乳化药物递送系统的制备与评价
Drug Dev Ind Pharm. 2009 May;35(5):603-11. doi: 10.1080/03639040802488089.
8
Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.使用自微乳化药物递送系统的喜保宁液体喷雾制剂。
Int J Pharm. 2007 Aug 1;340(1-2):84-91. doi: 10.1016/j.ijpharm.2007.03.021. Epub 2007 Mar 30.
9
Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.自乳化药物递送系统提高辅酶Q10的口服生物利用度。
Int J Pharm. 2009 Jun 5;374(1-2):66-72. doi: 10.1016/j.ijpharm.2009.03.008. Epub 2009 Mar 19.
10
Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems.自微乳药物传递系统提高大鼠他克莫司的口服生物利用度。
Drug Dev Ind Pharm. 2011 Oct;37(10):1225-30. doi: 10.3109/03639045.2011.565774. Epub 2011 May 26.

引用本文的文献

1
Self-nanoemulsifying drug delivery system for nebulization: fabrication and evaluation for systemic delivery of atorvastatin.用于雾化的自纳米乳化药物递送系统:阿托伐他汀全身递送的制备与评价
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3829-3842. doi: 10.1007/s00210-024-03494-w. Epub 2024 Oct 3.
2
Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice.尼氯硝唑基于脂质的自微乳给药系统增强了在小鼠原位人源肝癌移植瘤模型中的口服递送和抗肿瘤疗效。
Int J Nanomedicine. 2024 Mar 14;19:2639-2653. doi: 10.2147/IJN.S442143. eCollection 2024.
3
Self-emulsifying drug delivery systems: A versatile approach to enhance the oral delivery of BCS class III drug via hydrophobic ion pairing.
自乳化药物传递系统:一种通过疏水离子对提高 BCS 类 III 药物口服传递的多功能方法。
PLoS One. 2023 Jun 9;18(6):e0286668. doi: 10.1371/journal.pone.0286668. eCollection 2023.
4
Atorvastatin liposomes in a 3D-printed polymer film: a repurposing approach for local treatment of oral candidiasis.阿托伐他汀脂质体在 3D 打印聚合物薄膜中的应用:局部治疗口腔念珠菌病的再利用方法。
Drug Deliv Transl Res. 2023 Nov;13(11):2847-2868. doi: 10.1007/s13346-023-01353-4. Epub 2023 May 15.
5
Enhancing Oral Bioavailability of Domperidone Maleate: Formulation, Permeability Evaluation In-caco-2 Cell Monolayers and Rat Intestinal Permeability Studies.马来酸多潘立酮的口服生物利用度增强:制剂、Caco-2 细胞单层渗透评估和大鼠肠道渗透研究。
Curr Drug Deliv. 2024;21(7):1010-1023. doi: 10.2174/1567201820666230214091509.
6
Formulation and Evaluation of SNEDDS Loaded with Original Lipophenol for the Oral Route to Prevent Dry AMD and Stragardt's Disease.用于口服预防干性年龄相关性黄斑变性和斯特格氏病的载有原花青素的自乳化药物传递系统的制剂与评价
Pharmaceutics. 2022 May 10;14(5):1029. doi: 10.3390/pharmaceutics14051029.
7
A Customized Screening Tool Approach for the Development of a Self-Nanoemulsifying Drug Delivery System (SNEDDS).定制筛选工具方法在自微乳药物传递系统(SNEDDS)开发中的应用。
AAPS PharmSciTech. 2021 Dec 27;23(1):39. doi: 10.1208/s12249-021-02176-7.
8
Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.基于 Gelucire®的阿托伐他汀钙固体分散体的配方:体外溶出度和体内生物利用度研究。
AAPS PharmSciTech. 2021 May 24;22(5):161. doi: 10.1208/s12249-021-02019-5.
9
Enhanced intestinal lymphatic absorption of saquinavir through supersaturated self-microemulsifying drug delivery systems.通过过饱和自微乳化药物递送系统增强沙奎那韦的肠道淋巴吸收。
Asian J Pharm Sci. 2020 May;15(3):336-346. doi: 10.1016/j.ajps.2018.11.009. Epub 2019 Feb 14.
10
Enhancement of dissolution of atorvastatin through preparation of polymeric solid dispersions using supercritical fluid technology.通过超临界流体技术制备聚合物固体分散体提高阿托伐他汀的溶出度。
Res Pharm Sci. 2020 May 11;15(2):123-136. doi: 10.4103/1735-5362.283812. eCollection 2020 Apr.